AU2133695A - Inhibition of hiv-1 multiplication in mammalian cells - Google Patents

Inhibition of hiv-1 multiplication in mammalian cells

Info

Publication number
AU2133695A
AU2133695A AU21336/95A AU2133695A AU2133695A AU 2133695 A AU2133695 A AU 2133695A AU 21336/95 A AU21336/95 A AU 21336/95A AU 2133695 A AU2133695 A AU 2133695A AU 2133695 A AU2133695 A AU 2133695A
Authority
AU
Australia
Prior art keywords
hiv
multiplication
inhibition
mammalian cells
mammalian
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU21336/95A
Inventor
Sadna Joshi-Sukhwal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SADNA JOSHI SUKHWAL
Original Assignee
SADNA JOSHI SUKHWAL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SADNA JOSHI SUKHWAL filed Critical SADNA JOSHI SUKHWAL
Publication of AU2133695A publication Critical patent/AU2133695A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
    • C12N15/1132—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses against retroviridae, e.g. HIV

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • AIDS & HIV (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU21336/95A 1994-04-06 1995-04-05 Inhibition of hiv-1 multiplication in mammalian cells Abandoned AU2133695A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22356094A 1994-04-06 1994-04-06
US223560 1994-04-06
PCT/CA1995/000190 WO1995027783A1 (en) 1994-04-06 1995-04-05 Inhibition of hiv-1 multiplication in mammalian cells

Publications (1)

Publication Number Publication Date
AU2133695A true AU2133695A (en) 1995-10-30

Family

ID=22837034

Family Applications (1)

Application Number Title Priority Date Filing Date
AU21336/95A Abandoned AU2133695A (en) 1994-04-06 1995-04-05 Inhibition of hiv-1 multiplication in mammalian cells

Country Status (2)

Country Link
AU (1) AU2133695A (en)
WO (1) WO1995027783A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6776986B1 (en) 1996-06-06 2004-08-17 Novartis Ag Inhibition of HIV-1 replication by antisense RNA expression
EP2314700A1 (en) 1999-01-28 2011-04-27 Medical College of Georgia Research Institute, Inc Composition and method for in vivo and in vitro attenuation of gene expression using double stranded RNA
IL145778A0 (en) * 1999-04-21 2002-07-25 American Home Prod Methods and compositions for inhibiting the function of polynucleotide sequences
GB0012497D0 (en) * 2000-05-23 2000-07-12 Syngenix Ltd Antiviral therapy
US20020132257A1 (en) 2001-01-31 2002-09-19 Tony Giordano Use of post-transcriptional gene silencing for identifying nucleic acid sequences that modulate the function of a cell
GB0108065D0 (en) * 2001-03-30 2001-05-23 Syngenix Ltd Viral vectors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE208813T1 (en) * 1988-02-16 2001-11-15 Greatbatch Gen Aid Ltd MODIFIED CELLS WITH RESISTANCE TO RETROVIRAL INFECTIONS
EP0471796A4 (en) * 1989-05-10 1993-05-05 Sloan Kettering Institute For Cancer Research Stably transformed eucaryotic cells comprising a foreign transcribable dna under the control of a pol iii promoter
EP0578776A4 (en) * 1991-04-05 1995-04-12 Edison Animal Biotech Center Retrovirus inhibition with antisense nucleic acids complementary to packaging sequences.
EP0649466A1 (en) * 1992-07-02 1995-04-26 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Method of inhibiting viral replication
EP0598935A1 (en) * 1992-11-24 1994-06-01 Bayer Ag Expression vectors and their use to produce HIV-resistant human cells for therapeutic use
IL108719A0 (en) * 1993-02-25 1994-08-26 Ortho Pharma Corp Expression constructs containing hiv inhibitory antisense and other nucleotide sequences, retroviralvectors and recombinant retroviruses containing them

Also Published As

Publication number Publication date
WO1995027783A1 (en) 1995-10-19

Similar Documents

Publication Publication Date Title
AU7612196A (en) Functional human hematopoietic cells
AU1644295A (en) Cell culture substrates and methods of use
AU4754393A (en) Cell culture insert
AU4754493A (en) Cell culture insert
IL109008A0 (en) Immunoassy for determination of cells
AU6988596A (en) Photovoltaic cell
AU6489496A (en) Cell adhesion inhibitors
EP0734075A4 (en) Thin film solar cell
AU4831497A (en) Immortalized cells and uses therefor
AU2547195A (en) Crosslinked hybrid electrolyte film and methods of making and using the same
AU3470493A (en) Photovoltaic cell and method
AU6859996A (en) Hex metal on rectangular cells; metal or metal two is hex
AU5605994A (en) Methods for determining the presence of functional p53 in mammalian cells
AU4917396A (en) Electrical and structural interconnector
AU3936395A (en) Secondary lithium cell
AU9087891A (en) Electrochemical cell
AU6855796A (en) In vivo electroporation of cells
AU3773795A (en) Electrochemical cell
AU7252291A (en) Inhibition of human immunodeficiency virus -1 infectivity in human cells
AU1471195A (en) Analog multiplier using multitail cell
AU1052795A (en) Compositions and methods for transduction of cells
AU2133695A (en) Inhibition of hiv-1 multiplication in mammalian cells
AU1531695A (en) Electro-chemical cell
AU6130196A (en) Cell treatment
AU1685895A (en) Hematopoietic cell expansion and transplantation methods